BMRN
BIOMARIN PHARMACEUTICAL INC
BIOMARIN PHARMACEUTICAL INC (BMRN) has 14 SEC Form 4 filings (14 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jun 4, 2026.
Insiders have net sold $177K over the trailing 6 months.
- Industry:Biotechnology
- CEO:Alexander Hardy
- Employees:3,221
- HQ:San Rafael, CA, US
- IPO:1999-07-26
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$177K
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$12.0B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Friberg Gregory RFirst filing | EVP, Chief R&D Officer | Sale | 3,281 | $177K | May 11 | SEC ↗ |
Related companies
BIOMARIN PHARMACEUTICAL INC is in the Healthcare sector.